Overview

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

Status:
Completed
Trial end date:
2017-12-06
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of etanercept in adults with moderate to severe plaque psoriasis who have failed therapy with apremilast (Otezla).
Phase:
Phase 4
Details
Lead Sponsor:
Amgen
Treatments:
Apremilast
Etanercept